NYSEARCA:FBT First Trust NYSE Arca Biotechnology Index Fund (FBT) Price, Holdings, & News $146.67 -1.95 (-1.31%) (As of 09/21/2023 ET) Add Compare Share Share Today's Range$146.45▼$148.3150-Day Range$146.67▼$157.8952-Week Range$128.51▼$166.00Volume25,616 shsAverage Volume32,075 shsMarket Capitalization$1.33 billionAssets Under Management$1.29 billionDividend Yield0.00%Net Expense Ratio0.55% ProfileProfileChartHeadlinesHoldingsOptions ChainRatingsProfileChartHeadlinesHoldingsOptions ChainRatings About First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT)The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.Read More FBT Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart FBT ETF News HeadlinesApril 27, 2023 | seekingalpha.comFBT First Trust NYSE Arca Biotechnology Index Fund ETFMarch 17, 2023 | wsj.comNYSE Arca Securities Broker/Dealer IndexSeptember 21, 2023 | Behind the Markets (Ad)66,000% upside on tiny biotech?The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.March 11, 2023 | wsj.comNYSE Arca Gold BUGS IndexOctober 22, 2022 | fool.comFirst Trust NYSE Arca Biotechnology Index Fund (NYSEMKT: FBT)June 9, 2022 | investing.com2 Health Care And Biotech ETFs Poised For Robust Returns This YearJune 4, 2022 | finance.yahoo.comBest Biotech ETFs for Q3 2022February 25, 2022 | finance.yahoo.comBest Biotech ETFs for Q2 2022September 21, 2023 | Behind the Markets (Ad)66,000% upside on tiny biotech?The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.February 20, 2022 | finance.yahoo.comGet Ready for a Biotech ETF ComebackSee More Headlines Receive FBT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for First Trust NYSE Arca Biotechnology Index Fund and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerFirst Trust Fund NameFirst Trust NYSE Arca Biotechnology Index Fund Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:FBT Inception Date6/19/2006 Fund ManagerDaniel J. Lindquist, Jon Erickson David McGarel, RogerTestin, Stan Ueland, Chris Peterson, Erik Russo WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkNYSE Arca Biotechnology Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings31 Fund Statistics Assets Under Management$1.29 billion Average Daily Volume$47,783.10 Discount/Premium-0.24% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorFirst Trust Advisors L.P. CustodianThe Bank of New York Mellon Corporation DistributorFirst Trust Portfolios L.P. Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerRBC Capital Markets Miscellaneous Outstanding Shares9,100,000Beta0.79 Creation Unit50,000 Creation Fee$500.00 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report First Trust NYSE Arca Biotechnology Index Fund ExpensesTypeFBTHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.40%0.57%0.53%0.50%0.50%Other Expenses0.15%0.40%0.52%0.64%0.57%Total Expense0.55%0.72%0.69%0.74%0.69%Fee Waiver0.00%-0.51%-0.55%-0.70%-0.59%Net Expense0.55%0.61%0.59%0.57%0.57% First Trust NYSE Arca Biotechnology Index Fund (FBT) Holdings & ExposureTop 10 FBT HoldingsRegeneron Pharmaceuticals(NASDAQ:REGN)Holding Weight: 3.63%Amgen(NASDAQ:AMGN)Holding Weight: 3.61%Exelixis(NASDAQ:EXEL)Holding Weight: 3.58%Neurocrine Biosciences(NASDAQ:NBIX)Holding Weight: 3.58%BioMarin Pharmaceutical(NASDAQ:BMRN)Holding Weight: 3.51%Charles River Laboratories International(NYSE:CRL)Holding Weight: 3.49%Grifols(NASDAQ:GRFS)Holding Weight: 3.48%Sarepta Therapeutics(NASDAQ:SRPT)Holding Weight: 3.46%Seagen(NASDAQ:SGEN)Holding Weight: 3.46%Incyte(NASDAQ:INCY)Holding Weight: 3.45%FBT Sector ExposureFBT Industry ExposureFull Holdings Details Similar ETFsFirst Trust Health Care AlphaDEX FundNYSEARCA:FXHInvesco S&P 500 Equal Weight Health Care ETFNYSEARCA:RYHInvesco S&P 500 Equal Weight Health Care ETFNYSEARCA:RSPHDirexion Daily S&P Biotech Bull 3x SharesNYSEARCA:LABUiShares U.S. Healthcare Providers ETFNYSEARCA:IHFInstitutional OwnershipWestern Wealth Management LLCBought 3,272 shares on 8/30/2023Ownership: 0.062%Strategy Asset Managers LLCBought 3,076 shares on 8/25/2023Ownership: 0.034%GTS Securities LLCBought 35,455 shares on 8/16/2023Ownership: 0.390%Sunbelt Securities Inc.Sold 438 shares on 8/16/2023Ownership: 0.030%Harbour Investments Inc.Sold 87 shares on 8/15/2023Ownership: 0.095%View All Institutional Transactions FBT ETF - Frequently Asked Questions How have FBT shares performed in 2023? First Trust NYSE Arca Biotechnology Index Fund's stock was trading at $154.13 at the beginning of 2023. Since then, FBT stock has decreased by 3.6% and is now trading at $148.62. View the best growth stocks for 2023 here. What does FBT invest in? First Trust NYSE Arca Biotechnology Index Fund is a equity fund issued by First Trust. FBT focuses on health care investments and follows the NYSE Arca Biotechnology Index. The fund's investments total to approximately $1.29 billion assets under management. What stocks does First Trust NYSE Arca Biotechnology Index Fund hold? FBT invests in 31 holdings. Some of the stocks in their portfolio include Regeneron Pharmaceuticals (REGN), Amgen (AMGN), Exelixis (EXEL), Neurocrine Biosciences (NBIX), BioMarin Pharmaceutical (BMRN), Charles River Laboratories International (CRL), Grifols (GRFS), Sarepta Therapeutics (SRPT), Seagen (SGEN) and Incyte (INCY). What is the management fee for First Trust NYSE Arca Biotechnology Index Fund? First Trust NYSE Arca Biotechnology Index Fund's management fee is 0.40% and has other expenses of 0.15%. The net expense ratio for FBT is 0.55%. What other stocks do shareholders of First Trust NYSE Arca Biotechnology Index Fund own? Based on aggregate information from My MarketBeat watchlists, some companies that other First Trust NYSE Arca Biotechnology Index Fund investors own include Intel (INTC), Pfizer (PFE), Cisco Systems (CSCO), Walt Disney (DIS), Annaly Capital Management (NLY), ONEOK (OKE), Valero Energy (VLO), AbbVie (ABBV), Broadcom (AVGO) and Bristol-Myers Squibb (BMY). What is First Trust NYSE Arca Biotechnology Index Fund's stock symbol? First Trust NYSE Arca Biotechnology Index Fund trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "FBT." Who are First Trust NYSE Arca Biotechnology Index Fund's major shareholders? First Trust NYSE Arca Biotechnology Index Fund's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Wells Fargo & Company MN (4.90%), Raymond James Financial Services Advisors Inc. (2.59%), Royal Bank of Canada (2.50%), LPL Financial LLC (2.08%), Raymond James & Associates (1.40%) and Berger Financial Group Inc (1.21%). How do I buy shares of First Trust NYSE Arca Biotechnology Index Fund? Shares of FBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is First Trust NYSE Arca Biotechnology Index Fund's stock price today? One share of FBT stock can currently be purchased for approximately $148.62. How much money does First Trust NYSE Arca Biotechnology Index Fund make? First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) has a market capitalization of $1.35 billion. This page (NYSEARCA:FBT) was last updated on 9/21/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust NYSE Arca Biotechnology Index Fund Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.